Abstract
A propensity-matched cohort study compared injectable-naive patients with type 2 diabetes initiating exenatide once weekly (EQW) or basal insulin (BI), from 2012 through 2015, within a U.S. electronic health record database. A1C and weight were obtained as observed or multiply imputed values at baseline and quarterly for 1 year (Q1-Q4). Hypoglycemia and gastrointestinal symptoms were identified using diagnostic codes and clinical notes. EQW (n = 2,008) and BI (n = 4,016) cohorts were comparable at baseline (mean A1C and weight: EQW, 8.3% and 107.5 kg, respectively; BI, 8.5% and 107.9 kg, respectively). A1C declined in Q2: -0.69 and -0.50 percentage points for EQW and BI, respectively, with little further change in year 1. The EQW cohort lost 0.9 kg in Q1 and 1.9 kg by the end of the year; no weight change was observed in the BI cohort. Among EQW and BI cohorts, 25.9% and 14.3% achieved both glycemic control and weight loss, respectively. In the EQW and BI cohorts, the incidence of hypoglycemia per 1,000 person-years was 52.5 and 65.7, respectively. The incidence of nausea was greater among EQW relative to BI initiators (relative rate 1.18). EQW offers an advantage compared to BI in achieving glycemic control and weight loss and...Continue Reading
References
Jan 15, 2005·Pharmacoepidemiology and Drug Safety·John D SeegerAlexander M Walker
May 8, 2007·Primary Care·William F Miser
Sep 18, 2007·Pharmacoepidemiology and Drug Safety·UNKNOWN ISPE
Oct 25, 2007·Medical Care·John D SeegerAlexander M Walker
Apr 3, 2008·BMC Endocrine Disorders·Adit A GindeCarlos A Camargo
Sep 11, 2008·Lancet·Daniel J DruckerUNKNOWN DURATION-1 Study Group
Jan 29, 2010·American Journal of Epidemiology·Katherine J Lee, John B Carlin
Jul 9, 2010·Lancet·Michaela DiamantMichael Trautmann
Feb 24, 2012·Diabetes Care·Michaela DiamantMichael Trautmann
Jun 16, 2012·Journal of Diabetes and Its Complications·Setareh A WilliamsVivian Fonseca
Jan 1, 2013·Diabetes Care·Melanie DaviesJiten Vora
Jun 12, 2013·Postgraduate Medicine·Michael GrimmJaret Malloy
Aug 1, 2013·European Journal of Heart Failure·Mattia A E ValenteKevin Damman
Apr 16, 2014·The Lancet. Diabetes & Endocrinology·Michaela DiamantMichael E Trautmann
May 20, 2014·JAMA Internal Medicine·Kasia J LipskaHarlan M Krumholz
Mar 7, 2015·Mayo Clinic Proceedings·Carol H WyshamMichael E Trautmann
Apr 30, 2016·Clinical Therapeutics·Michael E TrautmannJames Ruggles
Citations
Jun 5, 2019·PloS One·Anita M LoughlinBenjamin Carroll
Apr 7, 2020·Diabetes, Obesity & Metabolism·John D SeegerAnita M Loughlin
Mar 7, 2020·Drugs·Digsu N KoyeSanjoy Ketan Paul
Jul 23, 2021·Pharmacoepidemiology and Drug Safety·Anita M LoughlinCheryl Enger